Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iryna Voloshyna

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 24, 2020
The role of interferon-γ in cardiovascular disease: an updateAilin Elyasi, Iryna Voloshyna, Saba Ahmed, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 13, 2016
COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophagesIryna Voloshyna, Lora J Kasselman, Steven E Carsons, et al.
Experimental Biology and Medicine (Maywood, N.J.)|September 4, 2013
Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophagesIryna Voloshyna, Sony Modayil, Michael J Littlefield, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 23, 2019
Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin AIryna Voloshyna, Isaac Teboul, Lora J Kasselman, et al.
Cancer Research|February 19, 2008
TREK-1 is a novel molecular target in prostate cancerIryna Voloshyna, Alessandra Besana, Mireia Castillo, et al.
Lipids|December 25, 2010
COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cellsKamran Anwar, Iryna Voloshyna, Michael J Littlefield, et al.
Medicina (Kaunas, Lithuania)|August 24, 2019
Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS SubstudyAllison B Reiss, Hirra A Arain, Lora J Kasselman, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol effluxIryna Voloshyna, Isaac Teboul, Michael J Littlefield, et al.
Journal of Traditional and Complementary Medicine|September 9, 2022
Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse modelLora J Kasselman, Heather A Renna, Iryna Voloshyna, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 17, 2024
Plasma from type 1 diabetes patients promotes pro-atherogenic cholesterol transport in human macrophagesSiham Accacha, Iryna Voloshyna, Lora J Kasselman, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 24, 2020
The role of interferon-γ in cardiovascular disease: an updateAilin Elyasi, Iryna Voloshyna, Saba Ahmed, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 13, 2016
COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophagesIryna Voloshyna, Lora J Kasselman, Steven E Carsons, et al.
Experimental Biology and Medicine (Maywood, N.J.)|September 4, 2013
Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophagesIryna Voloshyna, Sony Modayil, Michael J Littlefield, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 23, 2019
Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin AIryna Voloshyna, Isaac Teboul, Lora J Kasselman, et al.
Cancer Research|February 19, 2008
TREK-1 is a novel molecular target in prostate cancerIryna Voloshyna, Alessandra Besana, Mireia Castillo, et al.
Lipids|December 25, 2010
COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cellsKamran Anwar, Iryna Voloshyna, Michael J Littlefield, et al.
Medicina (Kaunas, Lithuania)|August 24, 2019
Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS SubstudyAllison B Reiss, Hirra A Arain, Lora J Kasselman, et al.
Experimental Biology and Medicine (Maywood, N.J.)|May 19, 2016
Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol effluxIryna Voloshyna, Isaac Teboul, Michael J Littlefield, et al.
Journal of Traditional and Complementary Medicine|September 9, 2022
Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse modelLora J Kasselman, Heather A Renna, Iryna Voloshyna, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 17, 2024
Plasma from type 1 diabetes patients promotes pro-atherogenic cholesterol transport in human macrophagesSiham Accacha, Iryna Voloshyna, Lora J Kasselman, et al.
Pageof 3